• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 28 个关节的改良银屑病关节炎疾病活动指数(DAPSA)能否充分评估银屑病关节炎患者的疾病活动度?

Can disease activity in patients with psoriatic arthritis be adequately assessed by a modified Disease Activity index for PSoriatic Arthritis (DAPSA) based on 28 joints?

机构信息

Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway

Division of Rheumatology, Department of Medicine, Hospital of Southern Norway Trust, Kristiansand, Norway.

出版信息

Ann Rheum Dis. 2018 Dec;77(12):1736-1741. doi: 10.1136/annrheumdis-2018-213463. Epub 2018 Sep 20.

DOI:10.1136/annrheumdis-2018-213463
PMID:30237203
Abstract

OBJECTIVE

To test the psychometric performance of a modified Disease Activity index for PSoriatic Arthritis (DAPSA) using 28 instead of 66 swollen/68 tender joint counts (SJC/TJC).

METHODS

We included patients with psoriatic arthritis (PsA) from the Danish national quality registry DANBIO, divided into examination (n=3157 patients, 23987 visits) and validation cohorts (n=3154 patients, 24160 visits). We defined DAPSA28 = (28TJC × conversion factor) + (28SJC × conversion factor) + patient global (0-10VAS) + pain (0-10VAS) + C reactive protein (CRP) (mg/dL). Identification of the conversion factors was performed by generalised estimating equations in the examination cohort and evaluation of in the validation cohort.

RESULTS

We estimated DAPSA28 = (28TJC × 1.6) + (28SJC × 1.6) + patient global (0-10VAS) + pain (0-10VAS) + CRP (mg/dL). DAPSA/DAPSA28 had comparable discriminative power expressed as standardised mean difference (DAPSA, 0.90; DAPSA28, 0.93) to distinguish between patients in high and low disease activity. Kappa with quadratic weighting of DAPSA/DAPSA28 disease activity states was high: 0.92 (95% CI 0.92 to 0.92). Standardised response means for DAPSA/DAPSA28 were -0.96/-0.92 for visits after biological DMARD-initiation. Baseline DAPSA/DAPSA28 had high correlation with 28-joint disease activity score with CRP (r=0.87/r=0.93), simplified disease activity index (r=0.92/r=0.99), p<0.001. Bland-Altman plot showed better agreement between DAPSA/DAPSA28 for low than high disease activity. DAPSA/DAPSA28 were similarly correlated to Health Assessment Questionnaire; r=0.60/0.62, p<0.001. DAPSA/DAPSA28 discriminated patients reporting their symptom state as acceptable versus not acceptable equally well: mean (SD) 9.1 (8.7)/8.4 (8.0) and 24.2 (14.9)/22.5 (13.8), respectively.

CONCLUSION

Our study suggests that data sets with only 28-joint counts available can be used to calculate DAPSA28, especially in patients with low disease activity. DAPSA28 showed good criterion, correlational and construct validity and sensitivity to change. Still, our results support that 66/68 joint count should be performed and the original DAPSA should be preferred in PsA.

摘要

目的

使用 28 个而不是 66 个肿胀/68 个触痛关节计数(SJC/TJC)来测试改良的银屑病关节炎疾病活动指数(DAPSA)的心理测量性能。

方法

我们纳入了来自丹麦国家质量登记处 DANBIO 的银屑病关节炎(PsA)患者,分为检查队列(n=3157 例患者,23987 次就诊)和验证队列(n=3154 例患者,24160 次就诊)。我们定义 DAPSA28 =(28TJC×转换系数)+(28SJC×转换系数)+患者整体(0-10VAS)+疼痛(0-10VAS)+C 反应蛋白(CRP)(mg/dL)。在检查队列中使用广义估计方程确定转换系数,并在验证队列中评估。

结果

我们估计 DAPSA28 =(28TJC×1.6)+(28SJC×1.6)+患者整体(0-10VAS)+疼痛(0-10VAS)+CRP(mg/dL)。DAPSA/DAPSA28 具有相似的鉴别能力,表现为标准化均差(DAPSA,0.90;DAPSA28,0.93),可区分高疾病活动度和低疾病活动度的患者。DAPSA/DAPSA28 疾病活动状态的二次加权kappa 值较高:0.92(95%CI 0.92 至 0.92)。DAPSA/DAPSA28 的标准化反应均值在生物 DMARD 起始后的就诊中分别为-0.96/-0.92。基线 DAPSA/DAPSA28 与 28 关节疾病活动评分与 CRP(r=0.87/r=0.93)、简化疾病活动指数(r=0.92/r=0.99)具有高度相关性,p<0.001。Bland-Altman 图显示,DAPSA/DAPSA28 在低疾病活动度下的一致性优于高疾病活动度。DAPSA/DAPSA28 与健康评估问卷同样相关:r=0.60/0.62,p<0.001。DAPSA/DAPSA28 同样可以很好地区分报告症状状态为可接受和不可接受的患者:平均(SD)分别为 9.1(8.7)/8.4(8.0)和 24.2(14.9)/22.5(13.8)。

结论

本研究表明,只有 28 个关节计数的数据集可用于计算 DAPSA28,尤其是在疾病活动度较低的患者中。DAPSA28 显示出良好的标准、相关性和结构有效性以及对变化的敏感性。尽管如此,我们的结果仍支持应进行 66/68 个关节计数,并在 PsA 中首选原始 DAPSA。

相似文献

1
Can disease activity in patients with psoriatic arthritis be adequately assessed by a modified Disease Activity index for PSoriatic Arthritis (DAPSA) based on 28 joints?基于 28 个关节的改良银屑病关节炎疾病活动指数(DAPSA)能否充分评估银屑病关节炎患者的疾病活动度?
Ann Rheum Dis. 2018 Dec;77(12):1736-1741. doi: 10.1136/annrheumdis-2018-213463. Epub 2018 Sep 20.
2
Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries.比较在九个欧洲国家开始使用首个人肿瘤坏死因子抑制剂的银屑病关节炎患者中 DAPSA、DAPSA28 和 DAS28-CRP。
Arthritis Care Res (Hoboken). 2024 Nov;76(11):1558-1565. doi: 10.1002/acr.25396. Epub 2024 Aug 19.
3
Residual symptoms and disease burden among patients with psoriatic arthritis: is a new disease activity index required?银屑病关节炎患者的残留症状和疾病负担:是否需要新的疾病活动指数?
Rheumatol Int. 2019 Jan;39(1):73-81. doi: 10.1007/s00296-018-4201-3. Epub 2018 Nov 13.
4
Evaluation of the Disease Activity index for PSoriatic Arthritis (DAPSA) with a quick quantitative C reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis: a prospective multicentre cross-sectional study.评估银屑病关节炎疾病活动指数(DAPSA)与快速定量 C 反应蛋白测定(Q-DAPSA)在银屑病关节炎患者中的应用:一项前瞻性多中心横断面研究。
RMD Open. 2022 Nov;8(2). doi: 10.1136/rmdopen-2022-002626.
5
Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score.银屑病关节炎(PsA)的疾病活动度:使用 DAPSA 评分定义缓解和治疗成功。
Ann Rheum Dis. 2016 May;75(5):811-8. doi: 10.1136/annrheumdis-2015-207507. Epub 2015 Aug 12.
6
Disease activity and response assessment in psoriatic arthritis using the Disease Activity index for PSoriatic Arthritis (DAPSA). A brief review.使用银屑病关节炎疾病活动指数(DAPSA)评估银屑病关节炎的疾病活动度和反应。简要综述。
Clin Exp Rheumatol. 2015 Sep-Oct;33(5 Suppl 93):S48-50. Epub 2015 Oct 15.
7
Ideal target for psoriatic arthritis? Comparison of remission and low disease activity states in a real-life cohort.银屑病关节炎的理想治疗靶点?真实队列中缓解与低疾病活动度状态的比较。
Ann Rheum Dis. 2018 Feb;77(2):251-257. doi: 10.1136/annrheumdis-2017-211998. Epub 2017 Oct 28.
8
Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase II Trial.银屑病关节炎的综合疾病活动指标:基于古塞单抗在一项干预性 II 期试验中的疗效比较仪器性能。
Arthritis Care Res (Hoboken). 2020 Nov;72(11):1579-1588. doi: 10.1002/acr.24046.
9
Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices.评估银屑病关节炎患者可接受的症状状态 (PASS):与疾病活动度和生活质量指标的相关性。
RMD Open. 2020 Mar;6(1). doi: 10.1136/rmdopen-2020-001170.
10
[A new integral enthesial-comorbididity index of psoriatic arthritis activity].[一种新的银屑病关节炎活动度的整体附着点合并症指数]
Ter Arkh. 2023 Jul 16;95(5):404-409. doi: 10.26442/00403660.2023.05.202197.

引用本文的文献

1
Validation of patient-reported outcome measures for dactylitis, psoriatic skin and nail disease, and uveitis in patients with psoriatic arthritis in routine care.在日常护理中对银屑病关节炎患者的指(趾)炎、银屑病皮肤和指甲疾病以及葡萄膜炎的患者报告结局指标进行验证。
RMD Open. 2025 Jul 5;11(3):e005705. doi: 10.1136/rmdopen-2025-005705.
2
Comparing the construct validity of measurement instruments for pain and stiffness in patients with axial spondyloartwhritis: cross-sectional analysis in the OASIS cohort.比较轴性脊柱关节炎患者疼痛和僵硬测量工具的结构效度:OASIS队列中的横断面分析
RMD Open. 2024 Dec 10;10(4):e004775. doi: 10.1136/rmdopen-2024-004775.
3
Core items to be included in a definition of moderate psoriatic arthritis: literature review and expert opinion.
中度银屑病关节炎定义中应包含的核心项目:文献回顾和专家意见。
Rheumatol Int. 2024 Nov;44(11):2327-2336. doi: 10.1007/s00296-024-05644-y. Epub 2024 Jul 6.
4
Filling the "GAP" in Real-World Assessment of Psoriatic Arthritis Disease Activity: Performance Characteristics of a Global/Pain Composite Endpoint.填补银屑病关节炎疾病活动度真实世界评估中的“空白”:一项全球/疼痛复合终点指标的性能特征
Rheumatol Ther. 2024 Oct;11(5):1101-1114. doi: 10.1007/s40744-024-00690-1. Epub 2024 Jul 2.
5
Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry.Janus 激酶抑制剂和肿瘤坏死因子抑制剂在类风湿关节炎、银屑病关节炎和脊柱关节炎中显示出良好的安全性和相似的持续性:来自 BIOBADASER 登记处的真实世界数据。
Ann Rheum Dis. 2024 Aug 27;83(9):1189-1199. doi: 10.1136/ard-2023-225271.
6
Prevalence of anxiety and depression and the association with self-management behaviour in >12 000 patients with inflammatory rheumatic disease: a cross-sectional nationwide study.超过 12000 例炎症性风湿病患者的焦虑和抑郁患病率及其与自我管理行为的相关性:一项全国性横断面研究。
RMD Open. 2024 Jan 22;10(1):e003412. doi: 10.1136/rmdopen-2023-003412.
7
Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases.阿达木单抗血清水平与抗药物抗体:与炎症性关节疾病的治疗反应和药物生存的关联。
Rheumatology (Oxford). 2024 May 3;63(6):1746-1755. doi: 10.1093/rheumatology/kead525.
8
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries.预测起始使用首个人肿瘤坏死因子抑制剂的银屑病关节炎患者 DAPSA28 缓解的因素:来自 13 个欧洲登记处的结果。
Rheumatology (Oxford). 2024 Mar 1;63(3):751-764. doi: 10.1093/rheumatology/kead284.
9
Gastrointestinal Symptoms Impact Psychosocial Function and Quality of Life in Patients with Rheumatoid Arthritis and Spondyloarthritis: A Cross-Sectional Study.胃肠道症状对类风湿关节炎和脊柱关节炎患者心理社会功能及生活质量的影响:一项横断面研究
J Clin Med. 2023 May 1;12(9):3248. doi: 10.3390/jcm12093248.
10
The impact of comorbidities on interleukin-17 inhibitor therapy in psoriatic arthritis: a Danish population-based cohort study.合并症对银屑病关节炎中白细胞介素-17抑制剂治疗的影响:一项基于丹麦人群的队列研究。
Rheumatol Adv Pract. 2023 Apr 3;7(2):rkad035. doi: 10.1093/rap/rkad035. eCollection 2023.